Evaluation of a Portable Device for Assessing Sleep Disordered Breathing in Congestive Heart Failure

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

35 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-07-31

Study Completion Date

2009-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate an approved, portable device for assessing Sleep Disordered Breathing in Congestive Heart Failure.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Evaluation of a New Sleep Algorithm

NCT01925430

Healthy

COMPLETED

Heart Function in Patients Assessed for Sleep Apnoea

NCT03226652

Heart Failure With Preserved Ejection Fraction Sleep Disordered Breathing Heart Failure With Normal Ejection Fraction +3 more

COMPLETED

Treatment of Sleep Disordered Breathing In Acute Decompensated Heart Failure Patients

NCT00804349

Heart Failure Sleep Apnea Syndromes

COMPLETED PHASE4

Obstructive Sleep Apnoea and Adipose Tissue Dysfunction

NCT02518633

Obstructive Sleep Apnoea Obesity Hypoxia

COMPLETED

Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease

NCT00738179

Sleep Apnea Cardiovascular Disease

UNKNOWN PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure, Congestive Sleep Apnea Syndromes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ApneaLink

A two channel sleep screening device for the assessment of Sleep Disordered Breathing.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Moderate to severe heart failure (as determined via Echocardiogram or treating physician)

Exclusion Criteria

* Clinically significant asthma requiring therapy
* Significant (parenchymal) lung disease
* Severe pulmonary hypertension
* Hypercapnia (PCO2 \> 60mmHg)
* Cardiogenic Shock
* Severe chronic renal failure
* Narcotic abuse/intravenous drug use (including heart failure due to alcohol abuse or chemotherapy, HIV+ and Hepatitis C)
* Methicillin- resistant Staphylococcus aureus infection
* Tracheotomy
* Enrolled in any concurrent study that may confound the results of this study
* Nocturnal positive airway pressure or oxygen
* Inability or refusal to sign patient consent form
* Inability or refusal to adhere to protocol requirements

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No